GB9521454D0 - Compositions for the treatment of conditions caused by herpes virus - Google Patents

Compositions for the treatment of conditions caused by herpes virus

Info

Publication number
GB9521454D0
GB9521454D0 GBGB9521454.0A GB9521454A GB9521454D0 GB 9521454 D0 GB9521454 D0 GB 9521454D0 GB 9521454 A GB9521454 A GB 9521454A GB 9521454 D0 GB9521454 D0 GB 9521454D0
Authority
GB
United Kingdom
Prior art keywords
compositions
treatment
herpes virus
conditions caused
caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9521454.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kappa Pharmaceuticals Ltd
Original Assignee
Kappa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kappa Pharmaceuticals Ltd filed Critical Kappa Pharmaceuticals Ltd
Priority to GBGB9521454.0A priority Critical patent/GB9521454D0/en
Publication of GB9521454D0 publication Critical patent/GB9521454D0/en
Priority to GB9621703A priority patent/GB2306324A/en
Pending legal-status Critical Current

Links

GBGB9521454.0A 1995-10-19 1995-10-19 Compositions for the treatment of conditions caused by herpes virus Pending GB9521454D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB9521454.0A GB9521454D0 (en) 1995-10-19 1995-10-19 Compositions for the treatment of conditions caused by herpes virus
GB9621703A GB2306324A (en) 1995-10-19 1996-10-18 A composition for the treatment of herpes infections comprising acyclovir and zinc

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9521454.0A GB9521454D0 (en) 1995-10-19 1995-10-19 Compositions for the treatment of conditions caused by herpes virus

Publications (1)

Publication Number Publication Date
GB9521454D0 true GB9521454D0 (en) 1995-12-20

Family

ID=10782578

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9521454.0A Pending GB9521454D0 (en) 1995-10-19 1995-10-19 Compositions for the treatment of conditions caused by herpes virus
GB9621703A Withdrawn GB2306324A (en) 1995-10-19 1996-10-18 A composition for the treatment of herpes infections comprising acyclovir and zinc

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9621703A Withdrawn GB2306324A (en) 1995-10-19 1996-10-18 A composition for the treatment of herpes infections comprising acyclovir and zinc

Country Status (1)

Country Link
GB (2) GB9521454D0 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY136633A (en) * 2001-01-17 2008-11-28 Berlin Chemie Ag Stabilized brivudine topical formulations
EP2283805A1 (en) 2009-07-28 2011-02-16 Sirvis BV Compositions comprising a zinc containing compound dissolved in a hydrophobic phase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661354A (en) * 1984-06-21 1987-04-28 Finnerty Edmund F Topical treatment of herpes simplex with a zinc sulfate-camphor water solution
GB8706052D0 (en) * 1987-03-13 1987-04-15 Medical Research Int Therapeutic compositions
CA1302887C (en) * 1987-11-24 1992-06-09 Yves Langelier Combination of acyclovir or a derivative thereof and bacitracin
DE4425322A1 (en) * 1994-07-18 1996-01-25 Merck Patent Gmbh Virostatics in a hydrophobic base for topical use

Also Published As

Publication number Publication date
GB9621703D0 (en) 1996-12-11
GB2306324A (en) 1997-05-07

Similar Documents

Publication Publication Date Title
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
IL117957A0 (en) Pharmaceutical compositions for the treatment of impotence
IL118004A0 (en) Vaccine compositions
AU3434393A (en) Targeted virus
EP0747116A3 (en) Process for the preparation of microcapsule compositions
GB9503863D0 (en) Vaccine compositions
GB9709360D0 (en) Methods for the treatment of herpes virus infections
GB9508791D0 (en) Compositions of matter
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
ZA977874B (en) Pharmaceutical compositions for treating viral diseases
ZA962208B (en) Soaker compositions
IL113057A0 (en) Compositions for the treatment of dandruff
IL118200A0 (en) Process for the preparation of substituted 2-fluoro-pyrimidines
GB9510162D0 (en) Compositions for the treatment of skin conditions
GB9521454D0 (en) Compositions for the treatment of conditions caused by herpes virus
ZA962210B (en) Soaker compositions
IL103907A0 (en) Ophthalmic compositions
IL120005A0 (en) Pharmaceutical compositions for the treatment of the eye
IL118973A (en) Process for the preparation of substituted aminocarbonyltriazolinones
GB9520504D0 (en) Composition for the treatment of conditions caused by herpes virus
GB9420317D0 (en) Composition for the treatment of conditions caused by herpes virus
GB9326554D0 (en) Composition for the treatment of conditions caused by herpes virus
AU7516098A (en) Immunomodulating, bile-derivable compositions for the treatment of viral disorders
AU3722593A (en) Compositions for the treatment of glaucoma
ZA962209B (en) Soaker compositions